 |
BioWorld-International-2010-01-27
Inspiration, Ipsen Try to Lock Up Hemophilia Market in $259M Deal
Inspiration, Ipsen Try to Lock Up Hemophilia Market in $259M Deal
LONDON - Inspiration Pharmaceuticals Inc. and Ipsen SA are merging their hemophilia portfolios in a deal that will see Ipsen invest $259 million to fund clinical development of the two lead products, while Inspiration handles the work. (BioWorld International)